Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

2.

The omega-3 index: clinical utility for therapeutic intervention.

Harris WS.

Curr Cardiol Rep. 2010 Nov;12(6):503-8. doi: 10.1007/s11886-010-0141-6. Review.

PMID:
20809235
3.

Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.

Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B.

Herz. 2004 Nov;29(7):673-85. Review. Erratum in: Herz. 2004 Dec;29(8):805.

PMID:
15580322
4.

Distribution, interconversion, and dose response of n-3 fatty acids in humans.

Arterburn LM, Hall EB, Oken H.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S. Review.

5.

Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".

Rupp H, Rupp TP, Wagner D, Alter P, Maisch B.

Herz. 2006 Dec;31 Suppl 3:30-49. Review.

PMID:
17575804

Supplemental Content

Support Center